BridgeMD
New treatment option for Trigeminal Neuralgia
Official title Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
ClinicalTrials.gov ID: NCT06278194
What this study is testing
- What it's testing
- Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Pain refractory to medical therapy for at least 3 months
- Planning radiofrequency thermocoagulation of gasserian ganglion
- Accept ultrasound measurements to be performed
You likely can't join if
- Refused to participate in the study
- Not attending follow-ups regularly
- Coagulation disorder
- Pregnancy
- Localized or systemic infection
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Başakşehir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Başakşehir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.